Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or ...
The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.